In gastric and ovarian cancers, ISA can inhibit PI3K/Akt signaling, leading to lowered ratio of Bcl-2 to Bax that facilitates apoptosis (Chun, 2023; Rasul et al., 2013b). Here, BCL2 is linked to ovarian cancer.